ActiPatch(TM) Brand and Product Awareness On the Increase
FREDERICK, Md., July 15 /PRNewswire-FirstCall/ -- BioElectronics Corporation, (Pink Sheets: BIEL), announced today that the company will resume airing an investment and product-related commercial on financial network Bloomberg Television. CEO of BioElectronics, Andrew Whelan says, "We previously ran this commercial in April with significant success relating both to our equity and product awareness. We are excited to see these commercials airing again today and reaching millions of people."
ActiPatch(TM), the product marketed by BioElectronics Corp. is changing the face of medicine and the way we heal. Recently chosen as "One of 9 Medical Breakthroughs That May Change Your Life," by MedicalHeadway.com, ActiPatch(TM) is fast becoming the treatment of choice for everything from soft tissue injuries to surgical recovery.
ActiPatch(TM) is a drug-free wafer thin patch with an embedded battery- operated microchip that delivers weeks of continuous pulsed RF therapy for less than a dollar a day. The unique ActiPatch(TM) delivery system, using patented technology, provides a cost-effective, home use method that reduces soft tissue pain and swelling, and accelerates healing.
ActiPatch(TM) is very thin, easily applied and comfortable to wear on an injured area. The patch effectively minimizes pain and swelling. Physicians are so impressed with the power of the patch that they are providing it to their patients for uses beyond plastic surgery recovery.
Distribution has expanded into Canada, Italy, Switzerland, Denmark, Scandinavian countries, Singapore, Malaysia and India.
For more information visit http://www.bioelectronicscorp.com or call 866-757-2284.
About BioElectronics Corporation
BioElectronics Corporation is the maker of the ActiPatch(TM).
ActiPatch(TM) is a drug-free anti-inflammatory
|SOURCE BioElectronics Corporation|
Copyright©2008 PR Newswire.
All rights reserved